An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension
Clinical trial NCT03514641 · COMPLETED
Trial details
- NCT number
- NCT03514641
- Sponsor
- Theracos
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-18
- Primary completion
- 2018-11-30
- Enrollment
- 673
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.